Medical Technology Breaking News: Aethlon Medical, Inc.
(OTCBB: AEMD) - "A Publication Describing the First Treatment of Ebola
with the Aethlon Hemopurifier(R)"
New
York, NY - February 13, 2015 (Investorideas.com newswire) Aethlon Medical, Inc.
(OTCBB:AEMD)
today published a new blog post on The Chairman's Blog, written by the
Company's Chairman and CEO, James Joyce. TheChairmansBlog.com is an exclusive
online media publication that enables key executive officers a unique platform
to share insights about their company and industry trends.
In today's blog, Mr. Joyce expands on the
manuscript entitled "Extracorporeal Virus Elimination for the Treatment of
Severe Ebola Virus Disease - First Experience with Lectin Affinity
Plasmapheresis", which was published February 11th, 2015 in the journal
"Blood Purification". The journal details the first administration of
Hemopurifier(R) therapy to an Ebola patient in Frankfurt, Germany. Read the
full blog post from Mr. Joyce on TheChairmansBlog.com. (http://www.thechairmansblog.com/aethlon-medical/james-joyce/publication-describing-first-treatment-ebola-aethlon-hemopurifier/.)
Read this release
in full at http://www.investorideas.com/CO/AEMD/news/2015/02132.asp
About Aethlon Medical, Inc.
Aethlon Medical creates targeted
therapeutic devices to address infectious disease, cancer and neurodegenerative
disorders. The company's lead product is the Aethlon Hemopurifier(R), a
first-in-class device that selectively targets the rapid elimination of
circulating viruses and tumor-secreted exosomes that promote cancer
progression. Exosome Sciences, Inc. is a majority owned subsidiary that is
advancing exosome-based products to diagnose and monitor cancer, infectious
disease and neurological disorders. For more information, please visit http://www.aethlonmedical.com/ and connect with
the Company on Twitter, LinkedIn, Facebook and Google+.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive,
online media publication where publicly and privately held firms alike share
insights about their companies and industries. TheChairmansBlog.com enables
upper tier management to discuss issues that are of importance to their
stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com.
SOURCE: TheChairmansBlog.com
Sign up
for the free investor news and stock alerts:
Disclaimer/Disclosure: The Investorideas.com newswire is a third party
publisher of news and research as well as creates original content as a news
source. Original content created by investorideas is protected by copyright
laws other than syndication rights. Investorideas is a news source on Google
news and Linkedintoday plus hundreds of syndication partners. Our site does not
make recommendations for purchases or sale of stocks or products. Nothing on
our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated by featured companies, news
submissions, content marketing and online advertising. Contact each company
directly for press release questions. Disclosure is posted on each release if
required but otherwise the news was not compensated for and is published for
the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Disclosure:
AEMD subscribes to the Investorideas newswire content publishing annual program
(9700 per Year, paid quarterly) for news publishing.
BC
Residents and Investor Disclaimer: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors
must adhere to regulations of each country.
Become an Investorideas.com Member and access our 14 online stock
directories 24/7 –biotech, defense, mining stocks, oil and gas stocks and
more...
1 comment:
According to preliminary ICSG data, the refined copper market balance for November 2014 showed an apparent production deficit of about 40000 metric tonnes (t). stocks to buy today
Post a Comment